Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Serotonin Uptake Inhibitors

Known as: Uptake Inhibitors, 5 Hydroxytryptamine, Reuptake Inhibitors, Serotonin, Inhibitors, 5-HT Uptake 
Compounds that specifically inhibit the reuptake of serotonin in the brain.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Abstract Genomic instability is a hallmark of cancer, and often is the result of altered DNA repair capacities in tumour cells… Expand
  • figure 1
  • figure 2
  • figure 3
Review
2019
Review
2019
Glutamate is the primary excitatory neurotransmitter in the central nervous system (CNS) which initiates rapid signal… Expand
Review
2019
Review
2019
Rationale & ObjectiveThe approved therapeutic indication for immune checkpoint inhibitors (CPIs) are rapidly expanding including… Expand
Review
2019
Review
2019
Poly (ADP-ribose) polymerases (PARPs) play an important role in various cellular processes, such as replication, recombination… Expand
  • figure 1
  • figure 2
  • table 1
Review
2019
Review
2019
Ovarian cancer remains one of the most challenging malignancies to treat. Targeted therapies such as poly (ADP-ribose) polymerase… Expand
Review
2019
Review
2019
BACKGROUND Numerous studies have identified potential risk factors and biomarkers for autism spectrum disorder. We aimed to study… Expand
  • figure 2
  • table 1
  • table 2
Review
2018
Review
2018
Defective DNA repair is a common hallmark of cancer. Homologous recombination is a DNA repair pathway of clinical interest due to… Expand
  • figure 1
Review
2018
Review
2018
OBJECTIVES The aim of Working Group 1 was to address the influence of different local (implant length, diameter, and design) and… Expand
Review
2018
Review
2018
Phosphodiesterase-4 (PDE4), mainly present in immune cells, epithelial cells, and brain cells, manifests as an intracellular non… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
Review
2017
Review
2017
Approximately 10% of pregnant women are prescribed antidepressant drugs (ADDs), with selective serotonin reuptake inhibitors… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3